Literature DB >> 16941146

Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy.

Jianhua Mao1, Yang Zhang, Lizhong Du, Yuwen Dai, Chunhu Yang, Li Liang.   

Abstract

There have been many exciting advances in our understanding of genetic causes of nephrotic syndrome since 1998 when nephrin was first found. The mRNA expressions of nephrin and CD2AP were studied by quantitative real-time polymerase chain reaction (PCR) in aspirated renal biopsy tissues from 9 subjects with minimal change nephrotic syndrome (MCNS), 6 with primary IgA nephropathy (IgAN), and 15 controls. Protein expression of nephrin, podocin, and CD2AP were analyzed by immunohistochemistry, indirect immunofluorescence, and laser confocal microscope. Compared with controls, the CD2AP mRNA level was significantly downregulated in renal samples from MCNS and IgAN patients (p=0.001 in MCNS, p=0.046 in IgAN), though no significant downregulation was found in the mRNA level of nephrin (p=0.346 in MCNS, p=0.311 in IgAN). The expression levels of protein CD2AP and nephrin were significantly reduced in MCNS and IgAN (MCNS: nephrin, p=0.034, CD2AP, p=0.005; IgAN: nephrin, p=0.021, CD2AP, p=0.025). The podocin staining did not differ significantly between controls and disease groups (p value 0.340 and 0.787, respectively). The results suggest that transcript and translation expression changes of nephrin and CD2AP may have pathogenetic roles in some patients with MCNS and IgAN in Chinese, though no correlation was found in podocin with proteinuria in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941146     DOI: 10.1007/s00467-006-0218-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

2.  Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved?

Authors:  Anne-Tiina Lahdenkari; Maija Suvanto; Eero Kajantie; Olli Koskimies; Marjo Kestilä; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2005-06-21       Impact factor: 3.714

3.  Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome.

Authors:  Annika Wernerson; Fredrik Dunér; Erna Pettersson; Silwa Mengarelli Widholm; Ulla Berg; Vesa Ruotsalainen; Karl Tryggvason; Kjell Hultenby; Magnus Söderberg
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

4.  Expression of nephrin in pediatric kidney diseases.

Authors:  Jaakko Patrakka; Vesa Ruotsalainen; Ilkka Ketola; Christer Holmberg; Markku Heikinheimo; Karl Tryggvason; Hannu Jalanko
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

5.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

6.  Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases.

Authors:  Shi-Xuan Wang; Maria P Rastaldi; Anu Pätäri; Heikki Ahola; Eija Heikkilä; Harry Holthöfer
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

7.  Expression of nephrin in acquired human glomerular disease.

Authors:  Wooseong Huh; Dae Joong Kim; Mi-Kyung Kim; Yoon Goo Kim; Ha-Young Oh; Vesa Ruotsalainen; Karl Tryggvason
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

8.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

Authors:  S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 9.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08

10.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  13 in total

1.  Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression.

Authors:  Sabrina Giglio; Aldesia Provenzano; Benedetta Mazzinghi; Francesca Becherucci; Laura Giunti; Giulia Sansavini; Fiammetta Ravaglia; Rosa Maria Roperto; Silvia Farsetti; Elisa Benetti; Mario Rotondi; Luisa Murer; Elena Lazzeri; Laura Lasagni; Marco Materassi; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

2.  Podocyte proteins in congenital and minimal change nephrotic syndrome.

Authors:  Maija Suvanto; Timo Jahnukainen; Marjo Kestilä; Hannu Jalanko
Journal:  Clin Exp Nephrol       Date:  2014-08-14       Impact factor: 2.801

3.  Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.

Authors:  Wenjing Wang; Yonghui Xia; Jianhua Mao; Yifang Chen; Dayan Wang; Huijun Shen; Haidong Fu; Lizhong Du; Ai'min Liu
Journal:  Pediatr Nephrol       Date:  2012-06-20       Impact factor: 3.714

4.  Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.

Authors:  Liming Wang; Mathew J Ellis; Timothy A Fields; David N Howell; Robert F Spurney
Journal:  Kidney Blood Press Res       Date:  2008-03-27       Impact factor: 2.687

5.  TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes.

Authors:  Sandhya Xavier; Thiruvur Niranjan; Stefanie Krick; Taoran Zhang; Wenjun Ju; Andrey S Shaw; Mario Schiffer; Erwin P Böttinger
Journal:  J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 10.121

6.  Relevance of VEGF and nephrin expression in glomerular diseases.

Authors:  Claudia A Bertuccio
Journal:  J Signal Transduct       Date:  2011-07-26

7.  Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration.

Authors:  Andrea Ranghino; Veronica Dimuccio; Elli Papadimitriou; Benedetta Bussolati
Journal:  Clin Kidney J       Date:  2014-12-30

8.  Triptolide Attenuates Podocyte Injury by Regulating Expression of miRNA-344b-3p and miRNA-30b-3p in Rats with Adriamycin-Induced Nephropathy.

Authors:  Chun-Bo Jiang; Ming-Gang Wei; Yue Tu; Hao Zhu; Chun-Qing Li; Wei-Min Jing; Wei Sun
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-20       Impact factor: 2.629

9.  Podocin and beta dystroglycan expression to study podocyte-podocyte and basement membrane matrix connections in adult protienuric states.

Authors:  Praveen B Shankar; Ritambhra Nada; Kusum Joshi; Ashwani Kumar; Charan Singh Rayat; Vinay Sakhuja
Journal:  Diagn Pathol       Date:  2014-02-21       Impact factor: 2.644

10.  Morphine induces albuminuria by compromising podocyte integrity.

Authors:  Xiqian Lan; Partab Rai; Nirupama Chandel; Kang Cheng; Rivka Lederman; Moin A Saleem; Peter W Mathieson; Mohammad Husain; John T Crosson; Kalpna Gupta; Ashwani Malhotra; Pravin C Singhal
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.